WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 4'2901 Infant (under 12 months) mortality rate: 12
GDP / capita (US$): 11'3051 Child (under 5 years) mortality rate: 12

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 2'897  2'890  2'883  2'881  2'886  3'122  3'281  2'681 
Births 40  39  38  37  36  51  79  72 
Surviving infants 39  38  37  36  35  50  76  69 
Pop. less than 5 years 185  179  170  163  158  279  388  335 
Pop. less than 15 years 537  547  559  574  595  945  1'073  964 
Female 15-49 years 732  733  732  731  731  798  827  644 

Number of reported cases

(Click for retrospective incidence data for Albania)
Diphtheria
ChartChart
  17 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  28  662 
Mumps
ChartChart
  20  18  39  1'651 
Pertussis
ChartChart
  16  89  329  137 
Polio*
ChartChart
 
Rubella
ChartChart
  1'752 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  15 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Albania)
Vaccine year result method % card seen                                                
BCG 2008  98  DHS   96  99*  99*  96  97  93  94 
DTP1 2008  100  DHS   96  99  99  99  99  98 
DTP3 2008  98  DHS   96  99  99  99  99  97  94 
DTP4          98  99 
IPV1          99 
HepB_BD          99  99*  97  97  98 
HepB3 2008  98  DHS   96  99  99  99  99  96 
Hib3          99  99  99  99 
JapEnc         
MCV1          98  99  98  99  95 
MCV2          98  99  99  99 
PCV1          99  99  99  99 
PCV3          99  99  99  99 
Pol3 2008  98  DHS   96  98  99  99  99  97 
Rota1         
RotaC         
RCV1          98  99  98  99 
TT2plus          75  89 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Albania)
BCG
ChartChart
  99  99  99  96  97  93  94  93 
DTP1
ChartChart
  99  99  99  99  99  98  97  97 
DTP3
ChartChart
  98  98  99  99  99  97  94  94 
HepB3
ChartChart
  98  98  99  99  99  96 
HepB_BD
ChartChart
  99  99  99  97  97  98 
Hib3
ChartChart
  98  98  99  99  99 
IPV1
ChartChart
 
MCV1
ChartChart
  98  98  99  98  99  95  88  90 
MCV2
ChartChart
  98  98  99  99  99 
PAB
ChartChart
  92  92  87  87  87  86  30 
PCV3
ChartChart
  99  99  99  99  99 
Pol3
ChartChart
  98  98  99  99  99  97  89  92 
RCV1
ChartChart
  98  98  99  98  99 
RotaC
ChartChart
 

Number of districts in the country 36  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 97
From 80 to 89% 3
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTwP 2 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Pediatric birth; Yes
IPV 2, 4 months; Yes
MMR 1, 5 years; Yes
OPV 6 months; 2, 6 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Rotavirus Yes From March 2016
Td 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2009-2013  2009-2013  2009-2013  2009-2013  2009 -2013  2009 -2013 
Nº of districts with microplans that include activities to raise immunization coverage number   36  36 

System performance

Total Nº districts in country number   36  36  36  36  36  36 
Nº districts with DTP3 coverage >=80% number   36  36  36  36  36  36 
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number   34  36  35  35  36  28 
% of districts with MCV1 coverage >=95% From 0 to 100%   94  100  97  97  100  78 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%     3-5  3-5  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.